A single weekly dose of imatinib is sufficient to induce and maintain remission of chronic eosinophilic leukaemia in FIP1L1-PDGFRA-expressing patients.

Source:http://linkedlifedata.com/resource/pubmed/id/18307562

Download in:

View as

General Info

PMID
18307562